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The  occurrence  of  synergism  or  antagonism  between  microorganisms  or 
viruses is generally known to workers in the field.  Even though the mech- 
anism  of  these  phenomena  is  by  no  means  well  understood,  the  fact 
that  the  course of an  infectious disease  may be significantly altered by the 
concomitant action and interplay of two different etiological agents, or their 
growth products, offers an attractive field for experimental investigation. 
As far as bacterial antagonism is  concerned, inhibitory effects are usually 
the result of a destructive action in vitro and in vivo of certain bacterial enzymes, 
like  pyocyanase,  gramicidin,  and  penicillin,  upon  certain  microorganisms. 
Among the protozoa, a well defined mutual suppression of two invading para- 
sites has been described for mixed infections of bartonella and eperythrozoon 
in mice  (1).  However, not until one  comes to the field of virus diseases  is 
interference  found  firmly  established  as  a  distinct  biological  phenomenon. 
Probably the first reference to domination of  one virus by another was made 
in  1929  by McKinney (2)  who reported that  a  yellow-mosaic virus, derived 
from  the  common  light-green  mosaic  of  tobacco,  would  not  propagate  in 
tobacco plants in which the common-mosaic virus was  already present.  Sub- 
sequent studies by McKinney (3) and others (4) have widened the scope of the 
interference phenomenon among plant viruses and added much to our knowl- 
edge of how to utilize this  reaction  as  a  possible  means  for establishing  rela- 
tionships  between  mutants  and  non-relationships  between  distinct  viruses. 
Examples of interference in virus infections of animals and man are not very 
numerous, nor have those on record received more than scant attention.  What 
appears as evidence of crossed resistance has been described for certain virus 
systems, i.e. pseudorabies-virus B  (5)  and vaccinia-herpes (6); but such  pro- 
tection as may be observed in these cases is probably due to an overlapping 
group immunity rather than to any immediate reaction between the viruses 
themselves.  Other instances, however, may be quoted in which interference 
seems to occur because of mutual interaction, direct or indirect, between the 
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opposing viral agents.  Thus, a  peculiar type of resistance to superinfection 
has been recorded for both encephalitogenic and non-encephalitogenic strains 
of herpes virus in that a  second intracerebral dose, following shortly after a 
preliminary corneal or  intradermal dose,  causes a  mutual extinction of the 
effects of the two injections (7);  similarly, it is said that if rabbits  receive 
a  series of intravenous injections of fixed virus after subdural infection with 
street virus,  no rabies  develops  (8).  Furthermore, Hoskins  (9)  found that 
intramuscular injection of a  neurotropic strain of yellow fever virus, which 
is usually harmless for monkeys, protects these animals against simultaneous 
infection with  a  highly pathogenic  viscerotropic  strain  of  the  same  virus. 
Subsequently, Findlay and MacCallum (10)  showed that the injection of a 
mixture of Rift Valley fever and yellow fever virus into rhesus monkeys served 
to save a  majority of the animals from death by yellow fever infection; con- 
versely, a  single inoculation of mice with neurotropic yellow fever virus and 
pantropic Rift Valley fever virus definitely protected a  few mice against the 
latter disease and delayed the death of others.  A well marked sparing effect 
of the virus of lymphocytic choriomeningitis upon poliomyelitic infection in 
monkeys has also been described by Dalldorf and his associates (11).  In all 
these cases interference takes place with such rapidity, and the resulting pro- 
tection  is  limited  to  such  brief  intervals,  that  the  failure of  infection can 
hardly be ascribed to forces of acquired immunity, as generally denoted by 
this term.  Moreover, in the last two instances, antagonism occurs between 
serologically unrelated viruses, a  fact which would tend further to minimize 
the involvement of any specific  immunological effects. 
No explanation Call be given, at present, for these protective phenomena. 
Above all, it is uncertain whether one virus acts directly upon the other so as 
to produce  complete annihilation of both,  or whether the protection is due 
to  a  restriction  of  viral  propagation  in  selective  cell  territories  which  are 
shared by the two infectious agents.  Finally it is conceivable that one virus 
may elaborate  a  soluble  substance  which  checks  the  growth  of  the  other 
virus.  Such inhibitory substances, derived from and acting against the same 
virus, have already been demonstrated in tumor tissue of the Rous chicken 
sarcoma (12). 
It will be recalled that a powerful antagonism between the murine strain of 
SK  poliomyelitis  virus  and  poliomyelitis  monkey  virus  (SK  and  Aycock 
strains) was discovered previously in the course of this work (13).  Further 
progress  with  this  problem has recently been  reported  (14,  15).  It  is  the 
object of this communication to present in detail the experimental basis on 
which these observations rest and to record the results that can be  obtained 
in monkeys, infected with poliomyelitis virus, by administering murine virus 
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EXPERIMENTAL 
The  experimental work  is  presented  in  three  sections.  The  first  section 
deals with the results obtained by the inoculation of monkeys with mixtures 
in vitro prepared of murine and poliomyelitis virus; the second with attempts 
to protect monkeys against poliomyelitic infection by prophylactic administra- 
tion of murine virus; the third with efforts to block the course of poliomyelitis 
in monkeys by injecting murine virus at certain intervals following infection 
with monkey virus. 
Results  Obtained  with the  Intracerebral  Injection  of Mixtures  of Murine  and 
Poliomyditis  Virus  into  Rhesus  Monkeys 
Mixtures were prepared by combining 0.5 cc. of routine virus suspension  (obtained 
from the brain of mice paralyzed by SK murine poliomyelitis virus) with 0.5 cc. of 
monkey virus suspensions  (obtained from the cord of monkeys paralyzed by monkey 
passage poliomyelitis virus).  Swiss  mice, 12 to 15 gin., and rhesus monkeys, 1800 to 
2500  gin.,  were  used  throughout  this  work.  Immediately after their preparation 
these  mixtures,  in  a  volume of  1 cc.,  were injected  intracerebraUy into  monkeys. 
Since earlier experience  with tissue culture murine virus (15) had suggested that the 
effectiveness  of interference between the opposing viruses may depend upon certain 
quantitative relationships, routine and monkey virus were employed in graded doses. 
The strains of monkey virus used in  these  experiments were  the  Aycock and  the 
RMV virus.  Tests with SK monkey poliomyelitis virus were omitted, partly because 
effective  interference by mixing SK murine virus  (mouse  or culture virus) with SK 
monkey virus had previously been described (13, 15), and, partly because considerable 
difficulties were encountered in maintaining the SK strain of poliomyelitis virus at a 
uniformly high level of virulence in serial passages through monkeys.  The specificity 
of the interference was determined by injecting intracerebrally into monkeys control 
mixtures consisting  of poliomyelitis monkey virus in combination with (1) saline,  (2) 
normal mouse brain suspensions,  (3)  murine virus  brain suspension  inactivated by 
heating for ~  hour at 75°C., and (4)  herpetic (L.F. strain of  herpes  virus)  mouse 
brain suspension.  The results of these tests are brought together in Tables I and II. 
It will be seen from Table I  that  interference  between  murine  virus  and 
Aycock monkey virus occurred regularly at levels of 1:10 dilution of monkey 
virus and 1:10 dilution of routine virus; the same dose of murine virus inter- 
fered effectively with all higher  dilutions  of monkey virus, except a  dilution 
of 1 : 500.1  In some monkeys a transient weakness was observed after injection 
with mixtures  of the  two viruses, particularly those  containing  an excess of 
1 Brain and cord of this monkey, when sacrificed at the height Of paralysis, failed 
of transmission to monkeys with the production of paralysis, whereas transfer to mice 
induced paralysis.  The paralysis in this monkey, therefore, may have been caused 
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murine virus; this condition was probably caused by mouse virus activity.  It 
will further  be noted  that  the  effectiveness of interference  is  gradually  lost 
when successive dilutions of murine virus are combined with a  constant dose 
of Aycock virus.  Thus, of three monkeys receiving mixtures of Aycock virus 
1:10 and murine virus 1:100 one animal developed paralysis, of three monkeys 
receiving mixtures of Aycock virus 1 : 10 and murine virus 1 : 1000 two animals 
became paralyzed, whereas neither of two monkeys injected with mixtures of 
TABLE I 
Interference between Murine Virus and Monkey Virus (Aycock Strain) in 
Mixture Experiments 
Monkey virus 
0.5  cc. 
1:10 
1:100 
1:500 
1:1,000 
1:10 
lc 
1:10 
1:50 
1:10 
1:100 
1:500 
1:1,000 
1:10 
1:10 
Murlne virus 
0.5  cc. 
1:10 
1:10 
1:100 
1:1,000 
1:10,000 
Controls 
Saline 
1  : I0  (normal 
mouse brain) 
~c  c~ 
1 : 10  (heated mu- 
rine virus) 
i : I0  (herpetic 
mouse brain) 
Complete paralysis 
Result 
Partial  paralysis  No paralysis 
Aycock virus 1:10 and murine virus 1:10,000  escaped the disease.  Since all 
control monkeys injected with doses of Aycock virus ranging from 0.5 cc. of a 
1:10 to a  1:1000 dilution succumbed to paralysis it appears that 0.5 cc. of a 
1:10  dilution  of murine virus was capable of protecting against at least 100 
minimal  paralytic  doses  of  poliomyelitis  virus.  Normal  mouse  brain  and 
herpetic mouse brain exercised no protective action and the interfering principle 
in murine virus was evidently destroyed by heating for 1~ hour at 75°C. 
An inspection of Table II shows that similar interference could be obtained 
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effective interference began with a  combination of RMV virus diluted 1:100 
and a  dilution of 1:10 murine virus; the same dose of murine virus protected 
effectively against all higher dilutions of RMV virus.  When one estimates the 
degree of effectiveness of this interference and considers the fact that paralysis 
occurred in control animals injected with RMV virus dilutions up to 1:10,000, 
simple calculation shows that a dilution of murine virus of 1 : 10 was capable of 
protecting once more against at least 100 minimal paralytic doses of poliomye- 
litis virus. 
The above findings, obtained with two different strains of monkey poliomye- 
litis virus,  suggest  that  the  interference between murine  virus  and  monkey 
TABLE II 
Interference between Murine  Virus and Monkey Virus (RMV Strain) in Mixture Experiments 
Monkey virus 
0.5 cc. 
1:10 
1:100 
1:200 
1:500 
1:1,000 
1:5,000 
1:10,000 
1:200 
1:500 
1:1,000 
1:5,000 
1:10,000 
Murine virus 
0.5 cc. 
Complete paralysis 
1:10  1 
~  0 
c~  0 
"  0 
~  0 
c~  0 
~  0 
Controls 
Saline  1 
c~  0 
"  1 
Result 
Partial paralysis  No paralysis 
virus proceeds on some quantitatively fixed basis.  No precise formulation can 
be offered at this time of the actual quantitative relationships involved since 
virulence titrations of the two strains of poliomyelitis virus were not carried 
to their respective end points.  However, the available data indicate that 0.5 
cc. of a  1:10 dilution of murine virus will counteract at least 100 minimum 
paralytic doses of poliomyelitis virus, irrespective of the strain used, when such 
mixtures are injected intracerebrally into rhesus monkeys.  Upon injection of 
apparently balanced virus mixtures not much propagation of either virus seems 
to occur.  Thus, on one occasion in which a monkey was sacrificed on the 12th 
day following intracerebral injection of a  non-pathogenic mixture of the two 
viruses, only traces of murine  and of poliomyelitis virus could be recovered 
from brain, cord, or spleen, as determined by transfer of these tissues to mice 
and  monkeys.  Symptomless  survival  of  monkeys  following  intracerebral 132  RODENT  POLIOMYELITIS.  V 
injection with mixtures of murine and poliomyelitis virus rarely seems to induce 
any permanent immunity.  Thus, 4 of 5 such monkeys developed prostrating 
paralysis upon reinfection,  1 month later, with Aycock virus. 
Results  Obtained with the Administration  of Murine  Virus in Monkeys  before 
Infection  with  Poliomyelitis  Virus 
At various intervals before intracerebral infection with poliomyelitis virus (RMV, 
Aycock)  monkeys were given murine virus by the intravenous route.  The murine 
virus was prepared by grinding three infected mouse brains in 9 cc. of tissue culture 
murine virus fluid, to yield a  10 per cent virus suspension.  The suspension  was al- 
lowed  to settle for about 5 to 10 minutes and the turbid supernatant  was  used in 
amounts of 6 to 8 cc. for one intravenous dose; these injections  must be given very 
slowly in order to avoid shock.  Murine virus was given in repeated doses, varying 
from 3 to 5 injections,  each dose being administered on successive  days; the interval 
between the last injection of routine virus and poliomyelitic infection extended from 
2 weeks to 1 day.  One prophylactic series of murine virus injections,  in some cases, 
constituted the only mode of treatment; in other cases, multiple injections of routine 
virus were resumed at irregular intervals following infection with poliomyelitis virus. 
A total of five experiments were run;  in three experiments infection was produced 
by RMV virus  2 and in two by Aycock virus.  Each experiment contained a variable 
number of treated monkeys and an adequate number of untreated  controls, all of 
which  were infected with the same dose of poliomyelitis virus.  The results of the 
five experiments are listed in Table III which also gives all details concerning  tech- 
nical procedures. 
The results obtained in the five different experiments, as given in Table III, 
are not strictly comparable, inasmuch  as the  experimental conditions varied 
considerably  from test  to  test.  However it  appears  that  in  the  first  three 
experiments,  in  which  RMV  virus  was  used,  there  were  3  monkeys  in  a 
treated group of 14 animals which remained entirely free from symptoms and 
2  additional  monkeys which  developed atypical paralysis after greatly pro- 
longed incubation periods.  By contrast, all of 8 accompanying controls suc- 
cumbed  promptly  to  the  disease.  In  the  next  two  experiments  in  which 
Aycock virus was used  a  treated group of  12  monkeys included  10  animals 
which failed to show any paralytic symptoms whatsoever and 1 monkey which 
developed  delayed  paralysis,  whereas  all  of  11  accompanying controls  suc- 
cumbed to the disease in a  typical manner.  In the group of treated animals 
which had failed to develop paralysis 6 monkeys survived sufficiently long to 
be reinfected, 4 weeks later, with Aycock virus.  All 6 monkeys proved fully 
susceptible to reinfection. 
In evaluating the mechanism of protection in these experiments an impres- 
2 These experiments include  14 monkeys to which reference was made in an earlier 
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sion is gained that successful interference is governed not only by ensuring a 
proper quantitative  balance  between murine  and poliomyelitis virus  at  the 
time of their first interaction, but also by maintenance of a  continuous level 
of active murine  virus.  The existence of certain  quantitative  relationships 
between the two interfering viruses has already been demonstrated in direct 
mixture tests.  Moreover, as shown in earlier experiments (13), murine virus 
TABLE III 
Interference  etween  Murine Virus and Monkey Virus in Prophylactic Experiments 
Experi-  No. of 
ment  monkeys 
No. 
Mode of murine  Infection with  Result 
prophylaxis  monkey  virus 
Inter- 
val 
be- 
tween 
Ph  r°-  Strain  y- 
~xis 
and 
infec- 
tion* 
I  2 murine  5  injections  be-  2  wks.  RMV  0.5 cc.  1:10  1  (9  days) 
fore  infection 
2  "  "  "  lwk.  "  "  "  "  2  (9-11  "  ) 
2  controls  --  --  "  "  "  "  2  (6  "  ) 
iI  7 murlne  5  injections  be-  1 wk.  RMV  0.5 cc. 1:100  3  (9-12 days) 
fore infection 
3  controls  --  --  "  "  "  "  3  (5-6  "  ) 
III  3 murine  5  injections  be-  5  days  RMV  0.5 cc.  1:200  2  (16-19 days) 
fore infection 
3  controls  --  --  "  *'  "  "  3  (7-11  "  ) 
IV  3  murine  3  injections  be-  1 day  Aycock  0.5 cc.  1:50  0 
fore infection 
3  "  3  injections  be-  1  "  "  "  "  "  0 
fore  and 4  in- 
i 
ections  after 
nfection 
3  controls  ....... '  "  2  (7-8 days) 
V  6  murine  3  injections  be-  1 day  Aycock  0.5 ce. 1:50  i  (11 days) 
fore  and  4  in- 
jections  after 
infection 
8controls  --  --  "  "  "  "  8  (6-12  "  ) 
Injection  of 
murine  virus  Dose 
Totals  26 murine  9 
19 controls  18 
Complete  Partial 
paralysis  paralysis 
t (9 days) 
0 
0 
2 (10-12  days) 
;0 
1  (20  days) 
0 
1  (11 days) 
0 
No 
pa- 
ra!y- 
sis 
13 
0 
* This interval denotes the time elapsed between the last injection of  murine virus and 
infection with monkey virus. 
propagates itself in the monkey only to a limited extent and is ordinarily ex- 
creted within 1 or 2 weeks.  In the light of these considerations the greater 
success which attended the Aycock experiments as compared with the RMV 
experiments should cause no surprise.  In the first place, the dose of Aycock 
virus  used  was  not  of  overwhelming  virulence;  furthermore,  some  of  the 
treated animals received additional injections of murine virus after infection 
with poliomyelitis virus; finally, the interval which separated the last prophy- 134  RODENT POLIOMYELITIS.  V 
lactic injection of murine virus from the date of poliomyelitic infection was not 
over 1 day.  Obviously, in all these respects, the experimental conditions were 
much severer in those experiments in which RMV virus was used.  It remains 
to be seen whether equally good results can be obtained with both strains of 
poliomyelitis virus, provided adequate allowance is made for dosage of monkey 
virus,  dosage of murine  virus and,  particularly,  a  more favorable  spacing of 
intervals between injection of the two viruses. 
Results Obtained by the Administration  of Murine  Virus to Monkeys Following 
Infection  with Poliomyelitis  Virus 
The  experiments  described  in  this  section  were  undertaken  in  order  to 
determine  whether  the  injection  of murine  virus  in monkeys,  subsequent  to 
infection with poliomyelitis monkey passage virus, was capable of modifying 
or blocking the course of the disease. 
Three strains of monkey virus were employed in this work, i.e. the SK, the Aycock, 
and the RMV virus.  Infection with monkey virus was produced by intracerebral 
injection.  Following infection, certain  intervals  were allowed to elapse  before the 
introduction of routine virus by the intravenous route; these intervals varied from a 
few minutes (1st day of infection) to 96 hours (5th day of infection).  The infecting 
doses of Aycock and RMV virus, respectively, represented at least  20 to 50 minimal 
paralytic doses for each strain, i.e. Aycoek 0.5 ce. 1:10 to 1:50 dilution and RMV 0.5 
cc.  1:10 to 1:200 dilution; SK monkey virus was used in amounts of 0.5 cc.  1:10 to 
1 : 100 dilution, doses which fell within the approximate range of virulence of this par- 
ticular strain.  The dosage of murine virus varied widely from test to test.  While 
no attempt was made to determine the minimum amount of routine virus which would 
afford protection at various intervals, some monkeys in which treatment was begun on 
the day of infection received one single injection only of murine virus.  On the other 
hand, all monkeys in which treatment was delayed beyond the 1st day of infection 
were subjected to a series  of repeated injections (5 to 9 injections).  Such injections 
always extended over a period of several days (1 to 5 days) ; in some cases,  two injec- 
tions were given each day, in others only one dose of murine virus was administered 
daily.  The murine virus was prepared in the same manner as previously described 
for the prophylactic experiments, i.e. a single dose consisted of three infected mouse 
brains,  ground in 9 ee. of undiluted tissue culture virus fluid,  so as to yield a final 
virus concentration of 1 : 10.  Each experiment included a variable number of animals 
under  treatment  with  murine  virus  and  an  adequate  number  of control animals. 
The control animals were infected with the same dose of monkey virus and, for the 
greater part, remained entirely free from any form of control treatment; in one experi- 
ment the controls received an equal number of intravenous injections of normal mouse 
brain, suspended in uninoculated tissue culture fluid instead of murine virus prepara- 
tions.  Three experiments were carried out with  SK virus, three with RMV virus, 
and six with Aycock virus.  The results obtained are given in Tables IV, V, and VI. 
The  data  shown  in  Table  IV  indicate  that  monkeys which  had  received 
murine virus were well nigh completely protected against poliomyelitic infec- CLAUS  W,  J'UNGEBLUT  AND  MURRAY  SANDERS  135 
tion induced by SK virus.  This protection extended practically undiminished 
from the 1st day of the infection to the 96 hour interval.  Thus, among a total 
of 23  monkeys, treated between the  1st and 5th day during the incubation 
period of the disease,  20 remained entirely free from paralysis, whereas  of a 
total of 11 controls only 2 escaped paralysis.  Unfortunately, the SK monkey 
virus in these tests failed to paralyze all of the control animals; moreover,  in 
some  of  the  paralyzed  controls  paralysis was  only partial.  Such  marked 
fluctuations in the virulence of the SK monkey virus, in our experience, have 
TABLE  IV 
Interference between Murine Virus and Monkey Virus (SK Strain) in Therapeutic Experiments 
Experiment 
No. 
II 
III 
No. of 
monkeys 
1 murine 
6  " 
4 controls 
2  murine 
4  " 
4  " 
4 controls 
3 murine 
3  " 
3 controls 
23  murine 
11 controls 
Infection with 
monkey virus 
Dose 
0.5 cc.  1:100 
0.5 cc. 1: 100 
0.5 cc.  1:10 
Mode of murine therapy 
Interval between 
infection and therapy 
No interval 
5th day of disease 
No interval 
3rd day of disease 
5th  "  "  " 
3rd day of disease 
5th  "  "  " 
Injec- 
tions, of 
mu.rme 
Vlnl$ 
1 
5-8 
1 
5-6 
5-6 
5-7 
7 
Totals 
Com  - 
plete 
paraly- 
sis 
o 
o 
o 
o 
3 
Result 
Partial 
paraly- 
sis 
No pa. 
ralysi 
i  2 
I 
i  3 
i  4 
1 
20 
2 
been typical of this strain of virus and render it unsuitable for critical tests. 
The available  evidence, therefore, while suggesting that a definite therapeutic 
effect had been achieved,  could not be regarded as entirely conclusive. 
A more clear-cut  picture is presented by the data given in Table V, which 
lists the results obtained in monkeys infected with RMV virus.  It appears 
that of a total of 20 monkeys, treated with murine virus between the 1st and 
5th  day of the incubation period,  7 remained entirely free  from paralysis, 
whereas  all 9 accompanying controls  succumbed to the disease.  It will also 
be observed that 4 additional treated animals recovered with partial paralysis; 
on the other hand, no control animal survived the prostrating paralytic attack 
which is characteristic of the RMV strain.  Treatment with murine virus had 
therefore undoubtedly afforded a  considerable  degree  of protection against 
poliomyelitic infection induced by the RMV strain, particularly during the 
early preparalytic stage of the disease. 136  RODENT  POLIOMYELITIS.  V 
Essential confirmation of the results obtained with the SK and RMV strains 
of monkey virus can be found in the data given in Table VI which deal with the 
experiments  in which poliomyelitic  infection was produced by Aycock virus. 
It will be noted that of a total of 45 monkeys, treated with murine virus be- 
tween the 1st and the 5th day of the disease, 24 failed to show any paralytic 
symptoms, whereas all 30 controls developed paralysis; among the 30 paralyzed 
controls paralysis was partial in only 6 animals, the remaining 24 controls suc- 
cumbing to the disease with complete  prostration.  It should be added that 
among the 21 treated animals which developed paralysis (11 complete and 10 
partial), there were 4 monkeys which ran an atypical course  of the disease 
TABLE  V 
Interference between Murine Virus and Monkey Virus (RMV Strain) in Therapeutic Experiments 
Experiment 
No. 
II 
III 
Totals 
~0. Of 
monkeys 
3 murine 
3  " 
3 controls 
5 murine 
6  " 
3 controls 
3 murine 
3 controls 
Infection with 
monkey virus 
Dose 
0.5 cc. 1:10 
0.5 cc.  1:10 
Mode of murlne therapy 
Inj~- 
Interval between  tions of 
infection and therapy  murine 
No interval 
5th day of disease 
virus 
6 
7-8 
8-9 
6-9 
tom  - 
plete 
paraly- 
Result 
Partial  No pa- 
paraly-  ralysis  sis 
20 murine 
9 controls 
0.5 cc.  1:200 
No interval 
3rd day  of disease 
No interval 
sis 
0  3 
0  0 
4  7 
I  0  0 
inasmuch as paralysis occurred after greatly prolonged incubation periods  (16 
to 30 days).  The conclusion, therefore, seems justified that the administration 
of murine virus in monkeys infected with the Aycock strain of poliomyelitis 
virus had produced distinct therapeutic effects, especially when treatment was 
instituted within the first 48 hours of the incubation period of the experimental 
disease. 
When all observations relating to the treatment of experimental poliomyelitis 
by murine virus are considered as a whole, the combined figures of three experi- 
mental series indicate that among a total of 88 monkeys, which had received 
murine virus between the 1st and 5th day of the disease, 51 monkeys, or more 
than half (57 per cent), failed to show any paralytic symptoms, while in a group 
of 50 untreated controls only 2 monkeys (4 per cent) escaped the disease.  By CLAUS  W.  JUNGEBLUT  AND  MURRAY  SANDERS  137 
limiting the statistical analysis to an evaluation only of the efficacy of early 
treatment, begun on the day of infection with poliomyelitis virus, it becomes 
apparent that of a  total of 40 monkeys thus treated,  26 animals,  or almost 
two-thirds (65 per cent), remained free from paralysis, as compared with one 
single  non-paralytic survivor among 47  accompanying control animals.  By 
contrast, when treatment was delayed until 96 hours after poliomyelitic infec- 
tion, marked protection was  obtained only against  the  weak SK strain,  all 
treated animals infected with highly virulent RMV or Aycock virus succumbing 
to the disease like controls.  While the above data serve as a measure of the inci- 
TABLE  VI 
Interference between Murine Virus and Monkey Virus (A ycock Strain) in 
Therapeutic Experiments 
Experi- 
ment No. 
I 
II 
No. of 
monkeys 
1 murine 
1 control 
1 murine 
3 
3 
5 controls 
III  6 murine 
3 controls 
IV  4 murine 
4  " 
5 controls 
V  5 murine 
5  " 
5 controls 
VI  6 murine 
4  " 
__  11 controls [ 
Totals  45 murine  j 
130 controls  ] 
Infection  with 
monkey virus 
Dose 
0.5 cc. 1:10  ts  tt  . 
o,.,s %  1,,20 
o.5 ee. 1:20 
0.5 ee. 1:20 
0.5 ce. 1:50 
0.5 cc. 1:50 
Mode of murine therapy 
Inje~ - 
Interval between  tions  of 
infection and  murl Le 
therapy  viru 
No interval  1 
No interval  61 
3rd day of disease  7-8 
5th  "  "  "  6-7 
No interval  3-6 
No interval  7-9 
3rd day of disease  7-8 
No interval  J 
3rd day of disease  8 
No interval  99 
3rd day of disease 
Complete 
paralysis 
1 (30 days) 
0 
1 (10 days) 
0 
1 (7  days) 
s(s  "  ) 
4  (5-9  "  ) 
0 
3 (7 days) 
2 (9 days) 
0 
4  (5-6 days) 
2  (7-8 days) 
0 
3  (7-8 days) 
0 
1 (20  days) 
10 (6.-13  "  ) 
11 
24 
Result 
Partial 
paralysis 
0 
1  (9 days) 
0 
0 
2  (10 days) 
0 
1 (12 days) 
1 (7 days) 
0 
1 (10 days) 
1 (12  "  ) 
1 (12  "  ) 
1 (16  days) 
2 (8-9  "  ) 
2  (9  "  ) 
1 (11 days) 
1 (20  "  ) 
1  (13  "  ) 
10 
6 
No 
~araly- 
sis 
24 
0 
dence of the disease in the treated and the control group, the effects of treatment 
with murine virus can also be gauged by comparing the severity of the disease 
in the two groups of animals.  Such a comparison, whether applied to the total 
figures or to figures relating to early treatment, reveals that the percentage of 
prostrating paralysis in treated animals was always a fraction of that occurring 
in untreated control animals; i.e.,  22 per cent against 72 per cent for the total 
group, and 17 per cent against 82 per cent for the early treatment group.  That 
early treatment with murine virus, when successful, virtually aborts the ex- 
perimental disease, whereas delayed treatment, even though saving the animal 
from paralysis, is unable to prevent some form of subclinical infection, is also 138  RODENT  POLIOMYELITIS,  V 
strikingly demonstrated by the results of reinfection experiments.  Thus, in 
a group of 6 surviving monkeys, in which treatment had been begun on the 1st 
day of infection, none escaped paralysis upon reinfection with Aycock or RMV 
virus; by contrast, in another group of 9 surviving monkeys, which had been 
treated at the 48 or 96 hour interval, 8 proved resistant and only 1 susceptible 
to reinfection with the same viruses. 
Murine virus being capable of bringing about as powerful protective effects 
as would appear from these data, it may be pertinent to raise the question why 
it has not been possible to abort the disease in an even higher percentage of 
monkeys  during  the  early  stages  of  the  incubation  period.  This  question 
cannot be readily answered.  As far as the fate of murine virus is concerned, 
it apparently persists for some time,  in active form, in  the  central nervous 
system  of  monkeys  when  introduced  shortly  after  poliomyelitic  infection. 
For on three occasions, when monkeys injected with murine virus on the day 
of infection with poliomyelitis virus were sacrificed between the  1st and  7th 
day during the incubation period, transfers of brain and cord to mice revealed 
the  presence of large  amounts  of murine  virus.  On  the  other hand,  when 
monkeys developed poliomyelitis despite treatment with murine virus, it has 
usually been impossible to demonstrate any murine virus in the central nervous 
system of such paralyzed animals.  Thus, transfers to mice of brain and cord 
from 4 prostrate treated monkeys, carried out at intervals of from 1 to 3 days 
after the last injection of murine virus, gave no evidence of the existence of any 
active murine virus in these tissues.  All that can be said, therefore, is that the 
failure of interference seems to be associated with the absence of murine virus, 
while the data are  not inconsistent with the assumption that  successful inter- 
ference depends upon the persistence of murine virus in active form.  The lack 
of success in therapeutic experiments is therefore probably conditioned, partly by 
the existence of a proper balance between monkey and murine virus--as deter- 
mined by the initial quantities of virus injected and the rate of their subsequent 
propagation--and  partly by the maintenance of a  definite threshold  level of 
murine virus throughout the preparalytic stage of the disease.  The harmonious 
coordination of these variables may well be materially affected by certain indi- 
vidual variations in the response of any given monkey to the two viruses. 
DISCUSSION 
The data presented in this paper show that the murine strain of SK poliomye- 
litis virus is capable  of interfering with the development of poliomyelitic in- 
fection in rhesus monkeys.  Murine infection in mice, on the other hand, is not 
significantly influenced by the administration of monkey poliomyelitis virus; 
nor  was  the  growth  of  murine  virus  inhibited  in  tissue  cultures  to  which 
monkey poliomyelitis virus had been added.  This interference phenomenon, 
therefore, appears to be a unilateral reaction in that the stronger murine virus 
dominates  over  the  weaker,  simian  strains.  Such  interference,  as  can  be CLAUS  W. JUNGEBLUT  AND MIIRRA¥  SANDERS  139 
demonstrated in  monkeys, operates effectively not only against  the parent 
SK monkey strain but also against two other highly virulent strains of monkey 
passage virus, i.e. Aycock and RMV.  It is further evident that interference 
takes place, irrespective of whether monkey and murine virus are injected in 
form of in vitro prepared mixtures, or whether the two viruses are introduced 
by separate routes.  When routine virus is given intravenously to monkeys 
before or after intracerebral infection with monkey virus, distinct prophylactic 
and therapeutic effects may be obtained.  The limits of effective interference 
are set by certain critical thresholds of time and dosage which seem to govern 
the interaction between the two opI~osing viruses.  Thus, the weaker culture 
virus makes a less effective interfering agent than highly potent mouse passage 
virus (15), whereas cavian passage virus, which possesses even lower virulence, 
has given no clear-cut evidence of therapeutically effective interference (17). 
It may be  added that no protection occurs when intravenous injections of 
monkey virus are substituted for murine virus during the incubation period 
of  the  experimental  disease. 
The protection which is induced when murine virus interferes with the de- 
velopment of poliomyelitic infection in monkeys is probably not referable to 
any immunizing effects,  humoral or  cellular,  of  the  murine  strain.  Thus, 
previous experience has demonstrated that prolonged immunization of monkeys 
with poliomyelitis virus, be it of simian or of murine origin, causes but rarely 
a  state  of  resistance  sufficiently marked  to  protect  the  immunized animal 
against  intracerebral  infection  with  monkey  passage  virus.  Furthermore, 
protection in interference experiments is afforded in prophylactic as well as 
in therapeutic tests.  It must also be remembered that monkeys which have 
survived the experience of in vivo  interference between murine and monkey 
virus, as a rule, remain fully susceptible to subsequent reinfection with monkey 
virus.  All these observations point in the direction of an immediate, though 
transient reaction which differs, both in its speed and lack of persistence, from 
classical immunological processes. 
While it seems permissible to exclude immunity as being responsible for the 
observed protection, no explanation which pretends to have more than heuristic 
significance can  be  offered at  this  time for the  mechanism of interference. 
Rivers (18) has drawn attention to a general impression, prevailing among virus 
workers, that unhealthy animals are either more resistant or react less severely 
to certain virus maladies than do perfectly healthy animals.  Proceeding from 
this experience to a discussion of the known systems of viral interference he has 
suggested that normal cells might be more suitable for the multiplication of a 
virus than cells  rendered abnormal by previous contact with another virus. 
This, of course, is merely a suggestion and it becomes necessary to subject the 
available data to a critical analysis if we expect to reach a better understanding 
of these obscure phenomena. 
To begin with, it seems fairly obvious that the various manifestations of viral 140  RODENT POLIOMYELITIS.  V 
antagonism, which, for want of a  better term, have been loosely brought to- 
gether under the name of "interference,"  make up a rather heterogeneous group 
in so far as their modus operandi is concerned.  Such sparing effects, for in- 
stance,  as  are  demonstrable  between poliomyelitic and  lymphocytic chorio- 
meningitic infection, have probably no connection whatsoever with intrinsic 
properties of the inciting agents, since the two diseases are caused by totally 
unrelated  viruses.  The  simplest  explanation  of  the phenomenon would  be 
to assume that po!iomyelitis virus, on its way from brain to cord, is partially 
or completely intercepted by the barrier of an extensive inflammatory reaction 
which  constitutes  the  most  characteristic  feature  of  lymphocytic  chorio- 
meningitic lesions.  In other words, the failure of poliomyelitis virus to produce 
paralysis, in this instance, is probably due to an essentially mechanical restric- 
tion of virus to its primary site of inoculation.  On the other hand, different 
conditions seem  to  obtain  in  those  cases of viral interference in  which  the 
competing viruses  represent pathogenic and  non-pathogenic variants  of the 
same strain, or are otherwise closely related.  We are referring to such inter- 
ference as  occurs between  the  neurotropic and  viscerotropic descendants  of 
yellow fever virus or between the virus of yellow fever and the virus of Rift 
Valley fever; for even though the last two viruses and the diseases which they 
produce are seemingly unrelated, sufficient analogies exist to raise the question 
whether both viruses may not have originated from some common ancestral 
form (10).  Obviously, the interference that is demonstrable between the pan- 
tropic murine strain of SK poliomyelitis virus and the neurotropic simian strains 
of poliomyelitis virus falls into the  same category; and we probably do not go 
far astray by assuming that the basic mechanisms responsible for the several 
interference phenomena listed  in this group are very similar.  Certainly, all 
three  types  of  interference just mentioned  operate with  singular  efficiency 
since  protection can  be obtained  with  great  regularity  against  multiple  in- 
fecting doses of highly virulent virus.  As far as information is concerned that 
has  come  to  us  from a  study of  the  poliomyelitis  interference system,  the 
available data  suggest that  the success of interference is  associated with the 
survival, and failure with the absence,  of murine virus in the central nervous 
system of the monkey.  It may further be taken for granted that a  definite 
correlation exists between the potency level of murine virus, as determined by 
titration in mice, and its interfering ability, as tested in monkeys.  Protection, 
therefore, seems to result from domination of one virus over the other.  Pre- 
cisely what the mechanism of this domination is, is impossible to say at present. 
It may either be mediated, in some way, by a reaction on the part of mutually 
susceptible cells,  or else be brought about by direct virucidal interaction be- 
tween the two viruses themselves.  The first hypothesis seems the more plausi- 
ble since both viruses, though differentially pathogenic for monkeys and mice, 
possess the same affinity for the anterior horn cell which constitutes the selec- CLAUS  W.  ~UNGEBLUT  AND  MURRAY  SANDERS  141 
tive seat of the poliomyelitic lesion.  Such a "blockade" of susceptible cells by 
non-paralyzing murine virus might render these cells temporarily impregnable 
to an attack of paralyzing monkey virus because the orderly function of certain 
enzyme systems, necessary for successful propagation of monkey virus, has 
conceivably been disturbed by previous contact with murine virus.  However, 
it should be mentioned that positive interference has also been obtained with 
murine virus preparations which had been partially inactivated by exposure 
to ultraviolet light.  Such irradiated virus, innocuous for mice by intraperi- 
toneal injection though still mildly infectious by intracerebral test, has proven 
an effective interfering agent, on several occasions, in both therapeutic and 
mixture experiments.  The question arises, therefore, whether the interfering 
principle in murine virus is identical with the infectious unit itself, or whether 
interference is brought about by a  non-infectious substance,  existing as an 
integral part of this unit or occurring separately in soluble form.  It is hoped 
that further investigations, which are in progress, will help to throw light on 
this fundamental problem. 
SLrM~ARY AND  CONCLUSIONS 
I. The murine strain  of SK poliomyelitis  virus interferes  with the propaga- 
tion in rhesus monkeys of SK, Aycock, and RMV  poliomyelitis  monkey virus. 
2. This interference  is  demonstrable by intracerebral  injection  of  mixtures of 
murine and monkey virus prepared in vitro  as well  as by separate injection  of 
the two viruses  by diverse  routes. 
3. Mixture tests  carried  out with graded doses of murine and monkey virus 
show that 0.5 cc. of a I0 per cent suspension prepared from the brains of 
paralyzed mice is  capable of  counteracting at least  I00 minimal paralyzing doses 
of two strains  of monkey virus. 
4.  No  interference was  demonstrable  with  suspensions  of brains  infected 
with murine virus which had been inactivated by heating for 1~ hour at 75°C., 
or with suspensions prepared  from normal mice,  or with brain  suspensions 
prepared from mice infected with herpes virus. 
5.  When murine virus is introduced into monkeys by the intravenous route, 
before or after intracerebral infection with monkey virus, distinct prophylactic 
or therapeutic results may be obtained. 
6.  Analysis of the  figures shows that  the  success of interference depends 
upon (a) the size of the infecting dose of monkey virus, (b) the amount of murine 
virus injected, and (c) the choice of proper intervals between the injection of 
monkey and routine virus. 
7.  The mechanism of the interference phenomenon here described is discussed 
in the light of the available data. 
The authors wish to express their gratitude to Mr. Frank Vasi for his assistance 
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